Baclofen Patent Expiration

Baclofen was first introduced by Novartis Pharmaceuticals Corp in its drug Lioresal on Approved Prior to Jan 1, 1982. Other drugs containing Baclofen are Kemstro, Gablofen, Ozobax, Fleqsuvy, Ozobax Ds, Lyvispah. 38 different companies have introduced drugs containing Baclofen.

Baclofen Patents

Given below is the list of patents protecting Baclofen, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Lyvispah	US11491125	Baclofen formulations and methods of minimizing patient exposure to metabolite variations	Sep 29, 2041	Amneal
Lyvispah	US11850225	Baclofen formulations and methods of minimizing patient exposure to metabolite variations	Sep 29, 2041	Amneal
Ozobax	US10610502	Oral baclofen solutions	Aug 30, 2039	Metacel Pharms Llc
Lyvispah	US10792262	Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives	Jul 29, 2039	Amneal
Lyvispah	US11654124	Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives	Jul 29, 2039	Amneal
Lyvispah	US11931328	Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives	Jul 29, 2039	Amneal
Fleqsuvy	US11324696	Suspensions and diluents for metronidazole and baclofen	Sep 29, 2037	Azurity
Fleqsuvy	US11446246	Suspensions and diluents for metronidazole and baclofen	Sep 08, 2037	Azurity
Kemstro	US6024981	Rapidly dissolving robust dosage form	Apr 09, 2018 (Expired)	Ucb Inc
Kemstro	US6221392	Rapidly dissolving robust dosage form	Apr 09, 2018 (Expired)	Ucb Inc

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List